| Revenue | 31/12/2016 | 31/12/2015 | 31/12/2014 | 31/12/2013 |
| Total revenue | 29,000 | 22,000 | 22,000 | 18,000 |
| Cost of revenue | 25,000 | 20,000 | 20,000 | 16,000 |
| Gross profit | 3,000 | 2,000 | 2,000 | 2,000 |
| Operating expenses |
| Research development | - | - | - | - |
| Selling general and administrative | - | - | - | - |
| Non-recurring | - | - | - | - |
| Others | - | - | - | - |
| Total operating expenses | 29,000 | 22,000 | 22,000 | 18,000 |
| Operating income or loss | - | - | - | -1,000 |
| Income from continuing operations |
| Total other income/expenses net | - | - | - | - |
| Earnings before interest and taxes | - | - | - | -1,000 |
| Interest expense | - | - | - | - |
| Income before tax | - | - | - | - |
| Income tax expense | - | - | - | - |
| Minority interest | - | - | - | - |
| Net income from continuing ops | - | - | - | - |
| Non-recurring events |
| Discontinued operations | - | - | - | - |
| Extraordinary items | - | - | - | - |
| Effect of accounting changes | - | - | - | - |
| Other items | - | - | - | - |
| Net income |
| Net income | - | - | -1,000 | -1,000 |
| Preferred stock and other adjustments | - | - | - | - |
| Net income applicable to common shares | - | - | - | - |
